JAMA October 17, 2017 Volume 318, Number15 1435 © 2017
- NealD. Barnard,MD, George Washington University School of Medicine and Health Sciences, Washington, DC. nbarnard @pcrm.org)
- Walter C. Willett, MD, DrPH, Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
- EricL.Ding,ScD, Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
- Meta-analyses almost always find Vitamin D benefits when their restrict their studies to similar situations
- Meta-analysis of Vitamin D category listing has
361 items along with related searches
Proof that Vitamin D Works contains the following
Many Clinical Trials have not found a benefit because of one or more of the following failures:
- Fails to use a large enough dose of vitamin D (often < 1,100 IU)
The Even larger dose needed if: 1) obese, 2) poor gut, 3) sick (many diseases consume lots of vitamin D)
- Fails to have given vitamin D for a long enough time (a few RCT lasted less than 5 weeks)
- Fails to have given Vitamin D frequently enough. At least every 2 months for D3) - and at least weekly for D2
Note: Infrequent dosing also causes unbalancing of the body's chemistry
- Fails to provide a loading dose, or had too short a duration to restore the vitamin D levels
- Fails to use D3 form, instead uses the less effective D2 form
- Fails to have a healthy range of Calcium or other important cofactors (especially for bone-related trials
Also, differences in Magnesium can result in 30% change in response to vitamin D
Magnesium is dependent on water, food, supplements
- Fails to notice the pre-existing vitamin D levels - only those who are low will likely show a benefit
- Fails to notice how/when the vitamin D was taken (which can change the response by as much as 2X)
- Fails to report on compliance (in one case 40% of the participants did not take the supplements consistently)
Many Meta-Analyses also do not find a benefit because one or more of the above failures
In addition, many meta-analysis average together ALL of the trials
Imagine a story about a meta-analysis of aspirin (which has never been done)
There would be scores of RCT for aspirin not working with 3 mg doses
There would be a many RCT of aspirin not working with 30 mg doses
There would be a few studies of aspirin WORKING with 300+ mg doses
There would be many studies of small amounts of Willow bark (Vitamin D2 instead of Vitamin D3)
Then there would be a meta-analysis of aspirin and Willow Bark
- That meta-analysis would conclude that aspirin and Willow bark do not work.
Controversial conclusions from meta-analyses in nutrition are of tremendous interest to the public and can influence policies on diet and health. When the results of meta-analyses are the product of faulty methods, they can be misleading and can also be exploited by economic interests seeking to counteract unflattering scientific findings about commercial products.
The term meta-analysis was coined by Glass in the mid-1970s for a set of techniques designed to characterize and combine the findings of prior studies in order to increase statistical power, provide quantitative summary estimates, and identify data gaps and biases. When applied to studies conducted with similar populations and methods, meta-analyses can be useful. However, many published meta-analyses have combined the findings of studies that differ in important ways, prompting Eysenck to complain that they have mixed apples and oranges—and sometimes "apples, lice, and killer whales'—yielding meaningless conclusions.1
Nutritional science presents special challenges for meta-analyses. In clinical trials, nutrition interventions vary from one study to the next in many methodological details, weakening the argument for combining their results. This is in contrast to studies of drugs in which it is generally easier to assess the comparability of interventions. In observational studies, populations range widely in their dietary habits, and while some diet characteristics (eg, coffee use) are fairly consistent for intake ranging from 6% to 7% of energy in vegan participants to approximately twice that amount in the other diet groups. Those in the highest tertile of saturated fat intake had nearly triple the risk of fatal ischemic heart disease compared with the lowest tertile.
In contrast, another study included in the metaanalysis, the Malmo Diet and Cancer cohort study,4 had no groups at the lower end of saturated fat intake, which ranged from 13% to more than 22% for the lowest to the highest quintiles, and no significant association between saturated fat intake and risk of cardiovascular events was detected. The Malmo authors cautioned, "only 1.2 percent of the present study population actually followed national Swedish recommendations (less than 10 energy percent) on saturated fat intake. Strictly speaking, the SFA-CVD [saturated fatty acids-cardiovascular disease] hypothesis is thus not fully testable in this population."
Nevertheless, the Malmo study was given substantial weight in the meta-analysis, which concluded that available evidence did not support limiting saturated fat, a conclusion repeated in a New York Times commentary proclaiming "Butter is Back" and a Time magazine cover displaying an artistic butter swirl and the bold headline "Eat Butter," and cited by the 2015 Dietary Guidelines Advisory Committee. The following year, a Gallup poll registered a sharp decline in the number of US adults limiting fat in their diets.
The food industry is well aware of the power of science-driven headlines and has invested in meta-analyses. In the process, nutritional science may be adversely affected.
individuals from day to day and are reliably reported, the consumption of most foods (eg, vegetables) and nutrients (eg, sodium) is variable and difficult to quantify. Different studies handle these issues in different ways. Moreover, different studies may report dietary intakes intertiles, quartiles, quintiles, or other groupings of their own choosing. Combining results may require contacting the original investigators for participant-level data, which may have been produced using dissimilar dietary assessment techniques.
A 2014 meta-analysis examined the relationship between saturated fat intake and coronary artery disease.2 One of the included prospective studies, the Oxford Vegetarian Study,3 included vegans, ovolacto vegetarians, fish eaters, and meat eaters, with reported saturated fat
The effects of any given dietary exposure depend on what that exposure is compared against. A2017 meta-analysis evaluated associations between red meat intake and blood lipid concentrations.5 Of the 39 trials that contributed to the analysison low-density lipoprotein (LDL) cholesterol, 34 compared red meat with other meats, revealing little apparent relation- ship with LDL cholesterol. The remaining 5 studies compared red meat to plant-based foods, most of which found nonsignificantly increased LDL cholesterol after red meat consumption. However, the investigators combined the results of all these studies, concluding that red meat "does not negatively influence cardiovascular disease risk factors." A better approach would focus on a single comparator and ensure that an adequate number of studies had used the method of interest.
In addition, eating less of one type of food often means eating more of something else. If some research participants consume less saturated fat, for example, what is taking its place—polyunsaturated fat, monounsaturated fat, complex carbohydrates, simple sugars, or something else? Understanding the effects of specific substitutions can lead to more robust and informative findings than focusing on the effects of one nutrient or food alone compared with everything else in a diet.
Studies vary greatly in quality. For example, some clinical trials are randomized; others are not. A 2014 meta-analysis of the effect of palm oil intake on blood lipids included studies that varied in quality, concluding that evidence was too inconsistent to draw firm conclusions.6 A later meta-analysis limited to higher-quality randomized trials found that palm oil significantly increased LDL cholesterol concentrations, compared with nontropical oils.7 The issue of the quality of individual trials is relevant for all meta-analyses, which reinforces the need to follow reporting guidelines, such as the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses), and include a rigorous assessment of risk of bias in individual studies, among other steps outlined below.
Combining the results of individual studies increases the total number of participants, and more participants should mean more statistical power. However, when there are differences in participant demographics and study methods, combining studies increases variability in findings that can reduce statistical power, making real effects more difficult to identify. So, for example, if saturated fat is associated with a disease outcome in an individual well-conducted study, but not in a meta-analysis, the null result may reflect heterogeneity among studies that dilutes real findings. Sensitivity analyses, which systematically remove some studies from the analysis, sometimes help by focusing, for example, on higher-quality studies.
The most important contribution of a meta-analysis is not necessarily the single statistical summary of effect size, but rather may be the ability to elucidate why different studies have produced different results. Subgroup analyses may help explain observed differences, and unexplained heterogeneity should be acknowledged. When individual studies vary substantially in their populations and methods, a meta-analysis may be less useful than a single (or small number of) well-conducted investigation(s).
The food industry is well aware of the power of science-driven headlines and has invested in meta-analyses. In the process, nutritional science may be adversely affected. In a 2007 review of 111 industry- funded studies, funding source was significantly related to study conclusions.8 Even in the absence of commercial funding, bias is an important consideration, so transparency in the conduct of metaanalyses is as important as it is in the individual studies.
Because meta-analyses, particularly involving diet, influence health policy, carry considerable weight in the media and in public perception, and have the potential to do harm, the peer-review process must go beyond ensuring that standard meta-analytic procedures have been followed.
This could include
- (1) requiring review by editors with expertise in meta-analysis and in the subject matter at hand,
- (2) requiring authors to confirm with the authors of the original reports that their data were appropriately represented, to the extent possible,
- (3) requiring authors to share their summary data and methodological details to allow others to reproduce the analysis, and
- (4) prioritizing meta-analyses derived by pooling original primary data over those using published summary data.
Potential conflicts of interest should be carefully scrutinized for meta-analyses and the studies they include. This process could be facilitated by a standardized, permanent financial disclosure registry.
These steps will not eliminate controversial findings from metaanalyses of nutritional research or of other topics but may give them a more solid foundation.
- Eysenck H. Meta-analysis squared: does it make sense? Am Psychol. 1995;50:110-111.
- Chowdhury R, Warnakula S, KunutsorS, etal. Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med. 2014;160(6): 398-406.
- Appleby PN,Thorogood M, Mann JI, KeyTJA. The Oxford Vegetarian Study: an overview. AmJ Clin Nutr. 1999;70(3)(suppl):525S-531S.
- Wallstrom P, Sonestedt E, Hlebowicz J, et al. Dietary fiber and saturated fat intake associations with cardiovascular disease differ by sex in the Malmo Diet and Cancer cohort: a prospective study. PLoS One. 2012;7(2):e31637.
- O'Connor LE, Kim JE, Campbell WW. Total red meat intake of >0.5 servings/d does not negatively influence cardiovascular disease risk factors:
- a systemically searched meta-analysis of randomized controlled trials. Am J Clin Nutr. 2017; 105(1):57-69.
- Fattore E, Bosetti C, Brighenti F, Agostoni C, Fattore G. Palm oil and blood lipid-related markers of cardiovascular disease: a systematic review and meta-analysis of dietary intervention trials. AmJ Clin Nutr. 2014;99(6):1331-1350.
- Sun Y, Neelakantan N, Wu Y, Lote-Oke R, Pan A, van Dam RM. Palm oil consumption increases LDL cholesterol compared with vegetable oils low in saturated fat in a meta-analysis of clinical trials. J Nutr. 2015;145(7):1549-1558.
- Lesser LI, Ebbeling CB, Goozner M, Wypij D, Ludwig DS. Relationship between funding source and conclusion among nutrition-related scientific articles. PLoS Med. 2007;4(1):e5.
shorturl = https://is.gd/misusemeta
- Fails to use a large enough dose of vitamin D (often < 1,100 IU)